ReviewIrish journal of medical science2026
Atopic dermatitis management: integrating disease mechanisms with precision medicine and nanotechnology-based targeted therapies.
Review in Irish journal of medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAtopic Dermatitis is a chronic, multi-factorial skin inflammation disorder characterized by immune dysregulation, skin barrier dysfunction, microbial imbalance and environmental triggers. Despite advances in conventional and biological therapies, challenges persist in early diagnosis, disease classification, treatment personalization and long-term management. Emerging technologies integrating precision medicine and nanotechnology offer promising solutions to address these limitations.
objectivesThis review aims to highlight the integration of precision medicine and advanced nanocarrier systems into the prediction, diagnosis and targeted treatment of atopic dermatitis.
methodThis review identifies key gaps in clinical, translational and personalized dermatological research. The review gives deep insights into current evidence on clinical practices and multi-omics approaches for AD phenotyping, biomarker discovery, disease severity assessment, and prediction of advanced therapeutic approaches.
resultsThe integration of multi-omics data approaches and translational research methods significantly enhance the classification of disease severity, and provides wonders in discovery of potential biomarkers for measuring response and suggesting treatment.
conclusionIntegrating these multidisciplinary approaches has the potential to optimize patient stratification, improve treatment outcomes, and advance sustainable dermatological care.
Indexed as
Identifiers
42809052What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.